Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm
AbstractBacteria on living or inert surfaces usually form biofilms which make them highly resistant to antibiotics and immune clearance. Herein, we develop a simple approach to overcome the above conundrum through lysozyme-associated liposomal gentamicin (LLG). The association of lysozyme to the surface of liposomes can effectively reduce the fusion of liposomes and undesirable payload release in regular storage or physiological environments. The LLG was more effective at damaging established biofilms and inhibiting biofilm formation of pathogens including Gram-positive and Gram-negative bacteria than gentamicin alone. This strategy may provide a novel approach to treat infections due to bacterial biofilm. View Full-Text
Share & Cite This Article
Hou, Y.; Wang, Z.; Zhang, P.; Bai, H.; Sun, Y.; Duan, J.; Mu, H. Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm. Int. J. Mol. Sci. 2017, 18, 784.
Hou Y, Wang Z, Zhang P, Bai H, Sun Y, Duan J, Mu H. Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm. International Journal of Molecular Sciences. 2017; 18(4):784.Chicago/Turabian Style
Hou, Yilin; Wang, Zhaojie; Zhang, Peng; Bai, Hu; Sun, Yuelin; Duan, Jinyou; Mu, Haibo. 2017. "Lysozyme Associated Liposomal Gentamicin Inhibits Bacterial Biofilm." Int. J. Mol. Sci. 18, no. 4: 784.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.